3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Clinical Trials in Cardiology
The design and execution of clinical trials in cardiology adhere to rigorous scientific and ethical standards. Large-scale trials often involve collaboration between multiple research centers and may span several years to gather robust and statistically significant data. Patient recruitment, informed consent, and adherence to strict protocols are fundamental aspects of conducting ethical clinical trials. The outcomes of these trials guide healthcare professionals in making evidence-based decisions about the adoption of new therapies, shaping clinical guidelines and influencing standards of care. As technology and understanding of cardiovascular diseases advance, clinical trials play a pivotal role in translating scientific discoveries into tangible benefits for patients, fostering innovation, and continuously improving the landscape of cardiology practice.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain